The history and present status of herbal products/neutraceuticals in The United States is briefly reviewed. A case is presented for further, more comprehensive, regulatory oversight than is presently the circumstance under the DSHEA act.
Mitscher, L.A.; Pillai, S.; and Shankel, D.M.
"Some transpacific thoughts on the regulatory need for standardization of herbal medical products,"
Journal of Food and Drug Analysis: Vol. 8
, Article 13.
Available at: https://doi.org/10.38212/2224-6614.2826
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.